MedeAnalytics

It ingests and unifies data across claims, enrollment, quality, and social determinants of health, then applies AI to predict and prioritize the highest-return cost and quality actions — such as which members to target for HEDIS gap closure or which utilization patterns are driving MLR deterioration. The platform packages those priorities into automated workflows and playbooks. MedeAnalytics positions its output as accountable action rather than passive dashboards.

The platform isolates medical-cost drivers by condition, cohort, provider, and site of care, then quantifies the margin impact of each. It surfaces avoidable utilization across inpatient, outpatient, and pharmacy spend, and predicts high-cost claimants before episodes occur. Those signals feed targeted initiatives that payers can deploy to measurably reduce MLR and administrative cost.

No. The firm pairs its AI-driven platform with embedded Strategic Advisors who assist in accelerating performance improvement. Its architecture includes Agentic AI and Managed Action™ workflows that operationalize the insights, making it a hybrid analytics-plus-execution offering rather than a standalone software license.

The firm works across commercial, Medicare Advantage, and Medicaid lines, with publicly cited expertise in employer-group performance reporting, Stars and HEDIS management, value-based contract operationalization, and network-performance optimization. Its marketing emphasizes performance measurement for risk-bearing entities broadly.

No public funding source is disclosed. The firm does not publish investors, ownership structure, or capitalization details through its corporate website or other accessible primary sources.